Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	39
Overall Study	STARTED	Tofa 10 mg	43
Overall Study	STARTED	PF-06650833 20 mg	39
Overall Study	STARTED	PF-06650833 60 mg	50
Overall Study	STARTED	PF-06650833 200 mg	50
Overall Study	STARTED	PF-06650833 400 mg	48
Overall Study	COMPLETED	Placebo	31
Overall Study	COMPLETED	Tofa 10 mg	42
Overall Study	COMPLETED	PF-06650833 20 mg	29
Overall Study	COMPLETED	PF-06650833 60 mg	46
Overall Study	COMPLETED	PF-06650833 200 mg	45
Overall Study	COMPLETED	PF-06650833 400 mg	44
Overall Study	NOT COMPLETED	Placebo	8
Overall Study	NOT COMPLETED	Tofa 10 mg	1
Overall Study	NOT COMPLETED	PF-06650833 20 mg	10
Overall Study	NOT COMPLETED	PF-06650833 60 mg	4
Overall Study	NOT COMPLETED	PF-06650833 200 mg	5
Overall Study	NOT COMPLETED	PF-06650833 400 mg	4

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02996500/flow